Titan Pharmaceuticals
TTNP
#10532
Rank
โ‚น0.57 B
Marketcap
โ‚น429.08
Share price
-3.76%
Change (1 day)
25.61%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น408.60. In 2023 the company made an earnings per share (EPS) of -โ‚น689.69 an increase over its 2022 EPS that were of -โ‚น1,414.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น689.69-51.22%
2022-โ‚น1,414-15.61%
2021-โ‚น1,675-81.37%
2020-โ‚น8,991-77.52%
2019-โ‚น40,004-56.32%
2018-โ‚น91,587-59.51%
2017-โ‚น2,26,219-371.81%
2016โ‚น83,226-144.35%
2015-โ‚น1,87,641300%
2014-โ‚น46,910-121.54%
2013โ‚น2,17,797-151.38%
2012-โ‚น4,23,867-11.54%
2011-โ‚น4,79,154188.89%
2010-โ‚น1,65,861-10%
2009-โ‚น1,84,290
2007-โ‚น7,55,590-2.38%
2006-โ‚น7,74,019-39.13%
2005-โ‚น12,71,602-16.87%
2004-โ‚น15,29,608-22.43%
2003-โ‚น19,71,9054.9%
2002-โ‚น18,79,76061.9%
2001-โ‚น11,61,028-13.7%
2000-โ‚น13,45,31865.01%
1999-โ‚น8,15,308-35.87%
1998-โ‚น12,71,385-1824.71%
1997โ‚น73,716-102.4%
1996-โ‚น30,77,646

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,037-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น670.14-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น132.17-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น80.98-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.27-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น362.06-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA